Sign up online today & collaborate
or click here to find out more
Disruptive thinkers, innovators, commentators and investors will be gathering in London in June at the inaugural PRISM series event to explore how new technologies and blue-sky thinking can support game-changing innovation in healthcare.
Addressing global healthcare needs is one of the Grand Challenges that the world faces, with the human population projected to be nearly ten billion by 2050, and healthcare systems worldwide already stretched by the cost of healthcare delivery to an ageing population.
The PRISM Series aims to unite business leaders from diverse backgrounds to ignite conversation and collaboration in order to deliver innovation in the healthcare and life sciences space. Interdisciplinary collaboration is essential in unleashing a new level of disruption around investment strategies, decision making, visionary science and technology.
The event will cover a range of topics including pushing the boundaries of artificial intelligence, cognitive diversity and innovation in healthcare.
> The morning session is on Innovation, Health and Medicine and asks how we optimize value creation from innovation. Speakers will challenge the audience and stretch their imagination to ignite new ways of looking at problems in the life sciences space. They include:
o Julie Frappier, Health Economist and President, Data 4 Actions - Innovation in healthcare and driving value for society
o Jackie Hunter CEO, Benevolent AI - Embracing the future to accelerate innovation – pushing the boundaries of AI
o Panel – “Is Technology the Answer to Our Economic Challenges?”
These discussions will be followed by a group of industry practitioners who will seek to connect the dots and continue to interact with audience to create new thinking.
> The afternoon session is on Future Success – What Does It Mean and How Do We Get There? and includes the following speakers:
o Laurent Audoly, Head of R&D, Pierre Fabre - Disruptive Innovation in Life Sciences
o Tony Sedgwick, Founder and Author, The Thought Disruptor - Cognitive Diversity
o Panel - Defining a Successful Next Generation Bio-Pharma Industry
o David Snowden, Founder and CSO, Cognitive Edge - An Organisation for Innovation
Guests will have an opportunity to interact with moderators, speakers, and other participants in order to create a cutting edge exchange platform that will lead to novel insights and actionable changes.
The event has been timed to coincide with the annual European Mediscience Awards, which celebrate successes and achievements across the sector.
Tony Sedgwick, a principle driver behind PRISM, said: “With the challenges we are facing in global healthcare, our goal is to bring a much more diverse group of thinkers to the table. Scientists as well as those from many different fields are needed to rise to the challenge. Cognitive diversity is the key to success.”
The event will take place on 15 June 2017 at the London School of Economics, 54 Lincoln’s Inn Fields, London WC2A 3LJ. Attendance is by invitation only and free of charge. To see the full agenda and to request an invitation, please visit www.thePRISMseries.global.
Notes to Editors
The PRISM Series is a joint venture between One Nucleus, Instinctif Partners and Lenus Group.
The London 2017 PRISM event (#PrismLDN17) is supported by the ABPI, Pierre Fabre, TRIUM Global Executive MBA, and the European Mediscience Awards.
About One Nucleus
One Nucleus is an international membership organisation for life science and healthcare companies. We are based in Cambridge with the majority of our members across the Cambridge/London corridor – at the heart of Europe’s largest life science and healthcare cluster. Vision: For One Nucleus and our members to be the top European life science and healthcare network Mission: We will achieve this by maximising the global competitiveness of our members.
For more information, please visit: www.onenucleus.com
About Instinctif Partners
Instinctif Partners is an international business communications consultancy and has recently been awarded International Agency of the Year at the PR Week Global Awards. Our global Life Sciences practice focuses on enhancing the value proposition for companies seeking investment, partnerships or customers. We work with clients to communicate their science and innovation to key stakeholders through the most relevant channels. We have specialist expertise and decades of experience in corporate, financial, healthcare and marketing communications, integrating visual and written communications with strategic counsel to deliver high impact programmes. Clients range from start-ups to multinationals, served from our headquarters in London and 20 offices globally including across Europe, AsiaPac and the USA.
For more information please visit http://lifesciences.instinctif.com
Sue Charles, Managing Partner, Instinctif Partners - Life Sciences, recently wrote an Insight on celebrating success in UK life sciences, which you can read here.
About Lenus Group
Lenus Group is a strategic advisor to the life sciences industry. We partner with clients to create dynamic and high performance organizations that fuel innovation and competitiveness. We are a network of current and formal industry leaders, researchers, subject matter experts and thought leaders from around the world. Drawing on our extensive industry knowledge and deep business acumen, we work with business leaders to achieve strategic and enduring outcomes faster.
For media enquiries:
Sue Charles/Daniel Gooch/Gemma Harris
+44 (0) 20 7457 2020